Correction to: Journal of Cell Communication and Signaling
Introduction
Pulmonary fibrosis is a very severe and life-threatening disease characterized by interstitial fibrosis in the lung parenchyma leading to reduced lung and diffusion capacity, with consequent respiratory failure and often death. Fibrosis is the final common pathway of maladaptive tissue remodeling and loss of organ function.
Cellular Communication Network factor 2 (CCN2; also known as Connective Tissue Growth Factor, CTGF) is an important mediator of fibrosis in virtually all organs, including the kidneys and the lungs (Pan et al. 2001; Wang et al. 2019). Myofibroblasts are the main effector cells during tissue fibrosis. Transformation of mesenchyme derived lung pericytes contributes importantly to the increase in myofibroblast numbers during pulmonary and kidney fibrosis, a process known to be CCN2 dependent (Shiwen et al. 2009; Hung et al. 2013).
The Fork head box D1 (FoxD1) transcription factor is transiently expressed in multiple mesenchymal cell types in several organs. FoxD1-derived mesenchymal cells, especially pericytes, contribute importantly to for example experimental kidney fibrosis and bleomycin induced pulmonary fibrosis (Hung et al. 2013). In the lung CCN2 is also an important mediator of the pericyte-endothelial interface (Hall-Glenn et al. 2012).
In order to generate a tool for the study of CCN2 expression by FoxD1-lineage cells to fibrotic tissue remodeling, we set out to establish a colony of FoxD1cre-CCN2flox/flox mice. Surprisingly however, FoxD1cre-mediated homozygous CCN2 deletion induced an early postnatal fatal phenotype characterized by pulmonary hypoplasia and postnatal asphyxiation. Moreover, we observed subtle axial skeletal defects which might have led to reduced breathing movements in utero and subsequent lethal impairment of lung development.
Materials and methods
Animals
CCN2flox mice were a kind gift from dr. A. Leask. The generation processes of FoxD1Cre and CCN2flox mice has been described extensively elsewhere (Liu et al. 2011; Kobayashi et al. 2014). FoxD1Cre and homozygous CCN2flox mice were cross-bred at least 5 generations prior to conduction of experiments. FoxD1Cre - CCN2flox/flox pups were severely asphyctic and euthanized by decapitation. Heterozygous (FoxD1Cre-CCN2flox/+) littermates showed no abnormalities, consistent with lack of a spontaneous phenotype in heterozygous constitutive CCN2 knockouts (Ivkovic et al. 2003). In subsequent experiments, mothers were killed before delivery on embryonic day (E)18.5 to prevent confounding secondary postnatal pathology. All fetuses in these litters were killed by decapitation immediately after opening the womb.
Immunohistochemistry
Whole embryos or selected tissues were embedded in paraffin blocks. Of these, 4 μm sections were cut, mounted on object slides and deparaffinized/rehydrated using sequential rinsing in xylene and 100%, 90% and 70% EtOH. Hematoxylin and eosin (H&E) and periodic acid Schiff (PAS) staining were performed using standard protocols as used in diagnostics at the department of pathology.
CD31/PDGFRβ double staining was performed as followed: Citrate (pH 6) boiling antigen retrieval (20 min), PBS(T) rinsing, anti-CD31 primary antibody incubation (LS-B4737 (LS Bio, Seattle WA); 1:50, 1.5 h room temperature), PBS(T) rinsing, Brightvision-AP (Immunologic, Duiven, the Netherlands) secondary antibody incubation (1 h), PBS(T) rinsing, Liquid permanent red (ThermoFisher, Waltham, MA) substrate development, PBS rinsing, Citrate boiling antigen retrieval (10 min), PBS(T) rinsing, anti-PDGFRβ primary antibody incubation (NB100–57343 (Novus, Contennial, CO); 1:200, overnight 4 ̊C), PBS(T) rinsing, Brightvision-AP incubation (45 min), PBS(T) rinsing, Vector Blue (Vector, Burlingame, CA) substrate development, PBS rinsing, drying, xylene, coverslip.
RT-qPCR
RNA was isolated from tissues using Trizol (ThermoFisher), and 3000 ng was reverse transcribed into cDNA. RT-qPCR was performed on a LightCycler480 (Roche, Basel, Switzerland), using commercially available TaqMan primer assays (Col1a2, Mm00483888_m1; Ccn2, Mm01192933_g1; Elastin, Mm00514692_m1; Thermo Fisher). Using the delta-delta CT method, relative expression levels were calculated for each individual embryo, and the average expression levels of control embryos were set to 1.
Genotyping PCR and gel electrophoresis
Samples were lysed using direct lyse buffer (Viagen, Los Angeles, CA) after which genotyping PCR was performed (Primers: CCN2 Flox: Forward: 5′- gAA ACA gCA ATT ACT ACA ACg ggA gTg g − 3′, Reverse: 5′- gAA ACA gCA ATT ACT ACA ACg ggA gTg g − 3′. FoxD1 Cre:,Forward Wild type: 5′- CTC CTC CGT GTC CTC GTC -3′, Forward FoxD1 Cre: 5′- GGG AGG ATT GGG AAG ACA AT −3, Common reverse: 5′- TCT GGT CCA AGA ATC CGA AG −3′. After PCR, Midori green (Nippon Genetics, JPN) was added and samples were run on 1% agarose gel. For product size determination, a 1 kb PLUS DNA ladder (Invitrogen, cat no 10787–018) was used.
Whole mount skeletal stain
Whole mount skeletal staining protocol of fetal carcasses is extensively described elsewhere (Rigueur and Lyons 2014). Briefly, wholemounts were rinsed, and fixed in ethanol (95%) and acetone respectively. Cartilage was stained by Alcian blue immersion, after which mounts were rinsed in 70% and 95% EtOH respectively. Using potassium hydroxide (KOH; 1% w/v), mounts were pre-cleared. Alizarin red was used to stain calcified bone. This was followed by immersion in KOH/glycerol (1:1) solution to remove excess red staining before storage in glycerol. Lordosis was measured as follows. Embryos were photographed after careful lateral positioning. Using the approximate same cervical vertebra in each mouse, straight lines were drawn fitting the axis of the upper cervical vertebrae and of the lower vertebrae/ upper thoracic vertebrae. Using ImageJ, the angle between x and y was determined.
Statistics
Statistical significance between groups was tested using the Student-T test using GraphPad Prism Version 8.0.1 (GraphPad, San Diego, CA). A P value below 0.05 was considered statistically significant. Error bars represented SEM.
Ethics
All experiments were conducted with permission of the animal ethics committee of the University of Utrecht.
Results
FoxD1Cre driven CCN2 deletion leads to impaired lung development and postnatal asphyxia but unaltered expression of structural proteins
Upon birth, FoxD1Cre/CCN2flox pups showed a slight thoracic kyphosis and made gasping movements, became cyanotic and severely asphyctic (Supplemental Video 1). They were euthanized by decapitation. Body weight after birth was similar in both FoxD1Cre/CCN2flox/flox and WT/CCN2flox/flox groups (average 1.4-g, SEM ± 0.3). However, the lung to body weight ratio was reduced in FoxD1Cre/ CCN2flox/flox mice (WT/ CCN2flox/flox: 41.58 mg/g SEM± 1.28 and FoxD1Cre/ CCN2flox/flox: 36.23 mg/g SEM± 1.49 respectively; P < 0.05).
Analysis of PAS stained lung sections showed reduced potential airspace compared to WT/CCN2flox mice (P < 0.05; Fig. 1A and B). CD31 (endothelium) and PDGFRβ (pericytes) revealed no aberrancies in the endothelial/pericyte interface in FoxD1Cre/CCN2flox mice (Fig. 1C).
Type I pneumocytes are the most abundant cell type in the lungs. Podoplanin mRNA expression level as a surrogate marker for type I pneumocyte numbers, showed no difference between WT/CCN2flox/flox and FoxD1Cre/CCN2flox/flox mice (Fig. 1D).
The expression of Col1α2 mRNA was not significantly different (Fig. 1E), and also hydroxyproline/proline content was similar in both groups (Fig. 1F). The expression level of Elastin mRNA was significantly reduced in FoxD1Cre/ CCN2flox/flox mice (P < 0.05; Fig. 1G), but mass spectrometry analysis of isodesmin as a marker for elastin fibrils showed no significant difference (Fig. 1H).
CCN2 deletion in FoxD1-lineage derived cells in the lung does not affect pulmonary CCN2 mRNA expression level at late gestation
CCN2flox genotyping PCR of lung parenchyma at E18.5 shows a profound knock-out (KO) DNA band in FoxD1Cre positive CCN2flox/flox mice (Fig. 2A), indicating FoxD1Cre driven CCN2 recombination has occurred before E18.5. However, at E18.5 total pulmonary Ccn2 mRNA expression was not significantly lower compared to WT/CCN2flox mice (P = 0.07; Fig. 2B). This suggests that the contribution pulmonary FoxD1 lineage cells make to CCN2 production in the lung at this late developmental stage is limited.
Disturbance of axial skeleton development in FoxD1Cre/CCN2flox mice
In whole mount Alcian blue/Alizarin red stained skeletons, cervical lordosis was increased in FoxD1Cre/ CCN2flox/flox compared to WT/ CCN2flox/flox pups (Fig. 3A&B; P < 0.01). Additionally, the sternal length of FoxD1Cre/ CCN2flox/flox mice was significantly shorter when compared to WT/CCN2flox mice (Fig. 3C&D; P < 0.05).
Global microscopic assessment of Alcian blue, Collagen type 2 and Ki67 (immuno)histochemistry however showed no apparent differences in FoxD1Cre/ CCN2flox/flox compared to the WT/CCN2flox/flox littermates (data not shown).
CCN2flox PCR showed a much more pronounced KO band in fetal tail-, than liver DNA, suggesting that FoxD1-lineage cells contribute significantly to CCN2-expression during axial skeletal development (Fig. 3E).
Discussion
Here we show that loss of CCN2 from FoxD1-lineage cells leads to aberrant lung morphology with post-natal asphyxiation, and axial skeletal deformities.
In postnatal lungs, CCN2 is mainly expressed in terminal bronchiolar epithelium (Burgos et al. 2010), which does not derive from FoxD1 expressing progenitor cells (Hung et al. 2013). This explains why Ccn2 expression levels are not altered significantly in E18.5 FoxD1Cre/CCN2flox/flox lungs (Fig. 2). The lung hypoplasia in our FoxD1Cre/CCN2flox/flox mice is very similar to that in constitutive CCN2-knock out mice. CCN2 is expressed in the developing lung (Burgos et al. 2010), and it has been proposed that in constitutive CCN2 –KO mice the absence of pulmonary CCN2 expression in the developing lung itself contributes importantly to pulmonary hypoplasia (Baguma-Nibasheka and Kablar 2008), but the lung hypoplasia in constitutive CCN2-knock out mice has also been interpreted as being secondary to their profound skeletal deformities (Ivkovic et al. 2003; Baguma-Nibasheka and Kablar 2008).
Normal lung development requires a structurally well-developed thorax (Inanlou et al. 2005) (Cameron et al. 2009). As an important regulator of enchondral ossification, CCN2 is critically involved in normal skeletal development as evidenced by severe malformations in constitutive CCN2-knockout mice (Kubota and Takigawa 2007) (Ivkovic et al. 2003; Baguma-Nibasheka and Kablar 2008). Similarly, the axial skeletal deformities in our FoxD1Cre/CCN2flox/flox mice are most likely the direct effect of CCN2 silencing in FoxD1-lineage cells in the developing axial skeleton. This would also be consistent with the reported co-segregation of a human chromosome region spanning 5q13.2 to 13.4 including the FOXD1 gene, as a locus co-segregating with disease in multiple generations of a family with idiopathic scoliosis (Edery et al. 2011).
The similarity of the pulmonary phenotype of constitutive CCN2-knock out mice with the impaired development of fetal lungs of FoxD1Cre/CCN2flox/flox embryos in the current study suggests that also in the latter lung hypoplasia might have developed secondary to the skeletal deformities.
In summary, we report that targeted CCN2 deletion in cells expressing FoxD1 during embryonic development leads to a lethal phenotype associated with axial skeletal deformities and postnatal asphyxiation due to (possibly secondary) pulmonary hypoplasia.
References
Baguma-Nibasheka M, Kablar B (2008) Pulmonary hypoplasia in the connective tissue growth factor (Ctgf) null mouse. Dev Dyn 237:485–493. https://doi.org/10.1002/dvdy.21433
Burgos CM, Nord M, Roos A, Didon L, Eklöf AC, Frenckner B (2010) Connective tissue growth factor expression pattern in lung development. Exp Lung Res 36:441–450. https://doi.org/10.3109/01902141003714056
Cameron TL, Belluoccio D, Farlie PG et al (2009) Global comparative transcriptome analysis of cartilage formation in vivo. BMC Dev Biol 9:20–17. https://doi.org/10.1186/1471-213X-9-20
Edery P, Margaritte-Jeannin P, Biot B, Labalme A, Bernard JC, Chastang J, Kassai B, Plais MH, Moldovan F, Clerget-Darpoux F (2011) New disease gene location and high genetic heterogeneity in idiopathic scoliosis. Eur J Hum Genet 19:865–869. https://doi.org/10.1038/ejhg.2011.31
Hall-Glenn F, De Young RA, Huang B-L et al (2012) CCN2/connective tissue growth factor is essential for pericyte adhesion and endothelial basement membrane formation during angiogenesis. PLoS One 7:e30562. https://doi.org/10.1371/journal.pone.0030562
Hung C, Linn G, Chow Y-H, Kobayashi A, Mittelsteadt K, Altemeier WA, Gharib SA, Schnapp LM, Duffield JS (2013) Role of lung pericytes and resident fibroblasts in the pathogenesis of pulmonary fibrosis. Am J Respir Crit Care Med 188:820–830. https://doi.org/10.1164/rccm.201212-2297OC
Inanlou MR, Baguma-Nibasheka M, Kablar B (2005) The role of fetal breathing-like movements in lung organogenesis. Histology and Histopathology 20(4);1261–1266. https://doi.org/10.14670/HH-20.1261
Ivkovic S, Yoon BS, Popoff SN, Safadi FF, Libuda DE, Stephenson RC et al. (2003) Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development. Development (Cambridge, England) 130(12):2779–2791
Kobayashi A, Mugford JW, Krautzberger AM, Naiman N, Liao J, McMahon A (2014) Identification of a multipotent self-renewing stromal progenitor population during mammalian kidney organogenesis. Stem Cell Reports 3:650–662. https://doi.org/10.1016/j.stemcr.2014.08.008
Kubota S, Takigawa M (2007) Role of CCN2/CTGF/Hcs24 in bone growth. Int Rev Cytol 257:1–41. https://doi.org/10.1016/S0074-7696(07)57001-4
Liu S, Shi-wen X, Abraham DJ, Leask A (2011) CCN2 is required for bleomycin-induced skin fibrosis in mice. Arthritis Rheum 63:239–246. https://doi.org/10.1002/art.30074
Pan LH, Yamauchi K, Uzuki M, Nakanishi T, Takigawa M, Inoue H, Sawai T (2001) Type II alveolar epithelial cells and interstitial fibroblasts express connective tissue growth factor in IPF. Eur Respir J 17:1220–1227. https://doi.org/10.1183/09031936.01.00074101
Rigueur D, Lyons KM (2014) Whole-mount skeletal staining. Methods Mol Biol 1130:113–121. https://doi.org/10.1007/978-1-62703-989-5_9
Shiwen X, Rajkumar V, Denton CP, Leask A, Abraham DJ (2009) Pericytes display increased CCN2 expression upon culturing. J Cell Commun Signal 3:61–64. https://doi.org/10.1007/s12079-009-0053-7
Wang X, Cui H, Wu S (2019) CTGF: a potential therapeutic target for Bronchopulmonary dysplasia. Eur J Pharmacol 860:172588. https://doi.org/10.1016/j.ejphar.2019.172588
Acknowledgements
We thank dr. A. Leask for the kind donation of CCN2 flox/flox mice.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The online version of the original article can be found at https://doi.org/10.1007/s12079-020-00549-4
Electronic supplementary material
Video1
(14.8 mb)
Rights and permissions
About this article
Cite this article
Falke, L.L., He, N., Chuva de Sousa Lopes, S.M. et al. Correction to: FoxD1-driven CCN2 deletion causes axial skeletal deformities, pulmonary hypoplasia, and neonatal asphyctic death. J. Cell Commun. Signal. 14, 47–52 (2020). https://doi.org/10.1007/s12079-020-00559-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12079-020-00559-2